stable coronary heart disease
Conditions
Interventions
Stable coronary heart disease group:Integral score of Traditional Chinese Medicine Syndrome Scale
Sponsors
Shandong University of Traditional Chinese Medicine Affiliated Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Meets the diagnostic criteria for stable coronary heart disease in Western medicine; (2) Meets any of the traditional Chinese medicine diagnostic criteria for coronary heart disease in the "Guidelines for the Diagnosis and Treatment of Stable Angina Pectoris in Coronary Heart Disease"; (3) Patients who have a prescription for traditional Chinese medicine decoction during their first visit and experience relief of symptoms after taking it; (4) The subjects are aged between 18 and 75 years old with no gender restrictions; (5) Agree and sign the informed consent form
Exclusion criteria
Exclusion criteria: (1) Patients with ST-T changes on electrocardiogram caused by digitalis drugs myocardial hypertrophy left bundle branch block etc. (2) Patients with concurrent organ damage or disease: those with severe cerebrovascular disease (cerebral hemorrhage subarachnoid hemorrhage extensive cerebral infarction); Poor control of diabetes (fasting blood glucose>11 mmol/L) or patients with kidney disease and peripheral neuropathy; Decompensated heart failure (NYHA class III-IV) recurrent malignant arrhythmias poorly controlled stable angina (controlled systolic blood pressure = 180mmHg or diastolic blood pressure = 100mmHg); Individuals who have used pacemakers and have a history of cerebrovascular disease within one year; People with respiratory failure chronic lung disease accompanied by breathing difficulties; Individuals with renal insufficiency (creatinine greater than the upper limit of normal glomerular filtration rate (eGFR)<30ml/min/1.73m2); Abnormal liver function (ALT AST greater than 3 times the upper limit of normal); Gastrointestinal lesions or gastrointestinal surgery may affect drug absorption and other serious digestive system diseases; Patients with combined malignant tumors hematological disorders or other serious or progressive systemic diseases. (3) Research on patients with incomplete treatment (4) Pregnant and perinatal women (5) Individuals with mental illnesses who are unable to cooperate with the questionnaire survey
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptoms of the disease; | — |
Countries
China
Contacts
Public ContactYunlun Li
Shandong University of Traditional Chinese Medicine Affiliated Hospital
Outcome results
None listed